NCT00832533

Brief Summary

1.1 To detect reproducible variations of serum 25-hydroxyvitamin D levels throughout the course of one year in relationship to objectively measured levels of ultraviolet exposure. 1.2 To determine specific times within the year that would yield the most significant data that could be focused on in future, larger studies examining whether there are protective effects of serum vitamin D on the development of cutaneous melanoma

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 30, 2009

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
Last Updated

September 28, 2015

Status Verified

September 1, 2015

Enrollment Period

3 months

First QC Date

January 29, 2009

Last Update Submit

September 24, 2015

Conditions

Keywords

Vitamin DSerum 25-Hydroxyvitamin DUV exposureUltraviolet Light ExposureSkin Melanoma Advanced

Outcome Measures

Primary Outcomes (1)

  • To detect reproducible variations of serum 25-hydroxyvitamin D levels throughout the course of one year in relationship to objectively measured levels of ultraviolet exposure.

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

2 participants with Hispanic ethnicity are represented as well. Darker-skinned individuals, such as African Americans, produce considerably less vitamin D. Inclusion of African Americans will be critical. Asians and African Americans do develop melanoma, but at a rate ten times less than Caucasians and it does not appear to be related to sun exposure; thus, to include them at this time would not allow us to focus on the medically-related issue.

You may qualify if:

  • Light-skinned volunteers (Caucasians including Hispanics with slightly darker complexion)
  • years of age (5 men and 5 women)
  • Resident in the State of New Mexico
  • Indoor workers with no significant history of prolonged, excessive sun exposure
  • Willing to have a monthly blood draw
  • Willing to fill out the sun diary every day on different indoor/outdoor activities.
  • During the project time period potential pregnancy of women volunteers would change the risk category of the participants, and that is a reportable event to UNM HSC HRRC and the Clinical Trial Office.

You may not qualify if:

  • Diet high in oily fish (e.g. eating cod liver or sardines oil conserved products more than 2-3 times/week)
  • Oral vitamin D supplementation (over 1,000 IU/day amount)
  • Tanning bed use.
  • Existing pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universtiy of New Mexico - Cancer Center

Albuquerque, New Mexico, 87131-0001, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples and Buccal Smear

MeSH Terms

Conditions

Melanoma

Condition Hierarchy (Ancestors)

Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Claire Verschraegen, M.D.

    University of New Mexico Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2009

First Posted

January 30, 2009

Study Start

November 1, 2008

Primary Completion

February 1, 2009

Study Completion

January 1, 2010

Last Updated

September 28, 2015

Record last verified: 2015-09

Locations